1. Incidence of serious gastrointestinal events among tildrakizumab‐treated patients with psoriasis: Letter to the Editor. (8th May 2019) Authors: Gooderham, M.; Elewski, B.E.; Pariser, D.M.; Sofen, H.; Mendelsohn, A.M.; Rozzo, S.J.; Li, Q. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 33:Number 10(2019) Page Start: e350 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗